We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...
A PharmaSphere Inc. subsidiary didn’t mislead the US Patent and Trademark Office to obtain the patent at the center of an ...
21h
TipRanks on MSNFresenius Medical Care Secures €1.1 Billion Through Bond IssuanceFresenius Medical Care ( ($FMS) ) has shared an announcement. On April 1, 2025, Fresenius Medical Care successfully placed bonds totaling €1.1 ...
HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week ...
Fresenius, Danone and Proximus benchmarks shake off tariff turmoil ◆ Range of new issue concessions needed ◆ High orderbook attrition for those pushing hard on spread ...
Fresenius SE FRE0.03%increase; green up pointing triangle said it raised around 1.1 billion euros ($1.15 billion) after selling part of its Fresenius Medical Care FME 0.88%increase; green up ...
Fresenius SE raised close to €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well as exchangeable bonds linked to the dialysis firm, as it looks to cut debt and ...
March 4 (Reuters) - Dialysis firm Fresenius Medical Care (FMEG.DE), opens new tab shares fell 7.8% after German healthcare group Fresenius SE (FREG.DE), opens new tab sold part of its stake in the ...
JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology are part of the Zacks Screen of the Week article.
The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...
Zacks Research boosted their Q1 2025 EPS estimates for shares of Fresenius Medical Care in a report released on Tuesday, ...
In a report released today, Graham Doyle from UBS maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report), with a price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results